Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Guardian Wealth Advisors LLC NC

Guardian Wealth Advisors LLC NC reduced its holdings in Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating) by 64.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 525 shares of the medical research company’s stock after selling 962 shares during the quarter. Guardian Wealth Advisors LLC NC’s holdings in Thermo Fisher Scientific were worth $310,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in Thermo Fisher Scientific by 1.1% during the first quarter. Vanguard Group Inc. now owns 31,457,999 shares of the medical research company’s stock worth $18,580,667,000 after purchasing an additional 354,211 shares during the last quarter. BlackRock Inc. raised its holdings in Thermo Fisher Scientific by 3.8% during the fourth quarter. BlackRock Inc. now owns 30,982,611 shares of the medical research company’s stock worth $20,672,838,000 after purchasing an additional 1,143,333 shares during the last quarter. State Street Corp raised its holdings in shares of Thermo Fisher Scientific by 3.4% in the fourth quarter. State Street Corp now owns 16,223,173 shares of the medical research company’s stock worth $10,828,875,000 after acquiring an additional 529,712 shares during the last quarter. Capital Research Global Investors lifted its position in shares of Thermo Fisher Scientific by 2.3% in the fourth quarter. Capital Research Global Investors now owns 9,454,032 shares of the medical research company’s stock valued at $6,308,097,000 after acquiring an additional 208,075 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Thermo Fisher Scientific by 3.5% during the 4th quarter. Geode Capital Management LLC now owns 6,403,805 shares of the medical research company’s stock worth $4,261,136,000 after purchasing an additional 214,375 shares in the last quarter. 86.50% of the stock is owned by institutional investors and hedge funds.

Thermo Fisher Scientific Trading Up 1.7 %

NYSE TMO opened at $579.19 on Tuesday. Thermo Fisher Scientific Inc. has a one year low of $497.83 and a one year high of $672.34. The company’s 50 day moving average price is $567.33 and its 200 day moving average price is $558.48. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.13 and a current ratio of 1.65. The firm has a market capitalization of $226.92 billion, a price-to-earnings ratio of 30.82, a PEG ratio of 1.77 and a beta of 0.85.

Thermo Fisher Scientific (NYSE:TMOGet Rating) last posted its quarterly earnings results on Thursday, July 28th. The medical research company reported $5.51 EPS for the quarter, beating the consensus estimate of $4.92 by $0.59. Thermo Fisher Scientific had a net margin of 17.37% and a return on equity of 24.36%. The firm had revenue of $10.97 billion for the quarter, compared to analyst estimates of $9.95 billion. During the same quarter last year, the firm posted $5.60 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 18.3% compared to the same quarter last year. On average, sell-side analysts predict that Thermo Fisher Scientific Inc. will post 22.92 EPS for the current year.

Thermo Fisher Scientific Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Stockholders of record on Thursday, September 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Wednesday, September 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.21%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.39%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on TMO shares. Barclays decreased their price target on shares of Thermo Fisher Scientific from $685.00 to $595.00 and set an “overweight” rating on the stock in a research note on Monday. SVB Leerink raised their price target on shares of Thermo Fisher Scientific from $630.00 to $650.00 and gave the stock an “outperform” rating in a research note on Friday, July 29th. Morgan Stanley raised their price target on shares of Thermo Fisher Scientific from $670.00 to $678.00 and gave the stock an “overweight” rating in a research note on Friday, July 29th. Finally, Credit Suisse Group started coverage on shares of Thermo Fisher Scientific in a research note on Wednesday, August 24th. They set a “neutral” rating and a $675.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $655.64.

Insider Activity

In other news, CFO Stephen Williamson sold 15,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, August 12th. The shares were sold at an average price of $601.32, for a total transaction of $9,019,800.00. Following the sale, the chief financial officer now owns 43,944 shares in the company, valued at $26,424,406.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CFO Stephen Williamson sold 15,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, August 12th. The shares were sold at an average price of $601.32, for a total transaction of $9,019,800.00. Following the sale, the chief financial officer now owns 43,944 shares in the company, valued at $26,424,406.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Michael A. Boxer sold 7,283 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, August 8th. The shares were sold at an average price of $590.80, for a total transaction of $4,302,796.40. Following the sale, the senior vice president now owns 12,398 shares in the company, valued at approximately $7,324,738.40. The disclosure for this sale can be found here. Insiders have sold 55,397 shares of company stock worth $33,012,754 over the last 90 days. Company insiders own 0.43% of the company’s stock.

Thermo Fisher Scientific Profile

(Get Rating)

Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Further Reading

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.